Back to 
HRT Financial LP
HRT Financial LP
NVCT
Showing 1 of 2 quarters
Position history for HRT Financial LP's holdings in Nuvectis Pharma, Inc.
No. HRT Financial exited its NVCT (Nuvectis Pharma) position in Q3 2024. Its Q2 2024 13F listed 13,627 shares worth $86,000. HRT Financial first reported NVCT in Q2 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History